Essent vs NMI
ESNT and NMIH side by side, both in insurance carriers. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ESNT and NMIH compare
Essent is the larger company, worth 1.9 times as much as NMI ($6.0B against $3.2B).
On earnings, NMI is cheaper: it trades at 8.4× trailing earnings, against 9.3× for Essent.
NMI grew revenue faster over the last twelve months (7.5% versus 4.3% for Essent).
NMI keeps more of each dollar of sales as profit, with a net margin of 54.1% compared with 51.5% at Essent.
Essent pays a dividend yielding 1.6%; NMI does not pay one.
NMI scores higher on the StockData Score (12 against 10 for Essent), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ESNT | NMIH |
|---|---|---|
| Size and price | ||
| Market cap | $6.0B | $3.2B |
| Share price | $67.02 | $42.67 |
| Change, 1 year | 12.3% | 19.9% |
| Change, 5 years | 39.1% | 88.1% |
| Beta (5Y) | 0.75 | 0.67 |
| Employees | 514 | 225 |
| StockData Score | ||
| Total score | 10 | 12 (better) |
| Valuation score | 3 | 3 |
| Growth score | 0 | 3 (better) |
| Performance score | 3 | 6 (better) |
| Health score | 0 | 0 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 9.3× | 8.4× (better) |
| P/S | 4.6× | 4.4× (better) |
| P/B | 1.1× (better) | 1.2× |
| EV/EBITDA | 6.9× | 5.7× (better) |
| P/FCF | 7.3× | 7.3× (better) |
| PEG | – | 0.64 |
| FCF yield | 13.7% | 13.8% (better) |
| Fair value | $75.03 | $48.75 |
| Margin of safety | 10.7% | 12.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 4.3% | 7.5% (better) |
| Revenue growth, 5Y average | 5.7% | 10.3% (better) |
| Net income growth (TTM) | −4.8% | 4.7% (better) |
| EPS growth (TTM) | 4.7% | 7.9% (better) |
| EPS growth, 5Y average | 12.2% | 18.2% (better) |
| Profitability | ||
| Net margin | 51.5% | 54.1% (better) |
| FCF margin | 62.4% (better) | 60.4% |
| Return on equity | 12.0% | 15.4% (better) |
| Financial health | ||
| Altman Z-score | 3.07 (better) | 2.44 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.6% | – |
| Payout ratio | 18.2% | – |
| Years of dividend growth | 6 | – |
| Dividend growth, 5Y average | 14.1% | – |
| Buyback yield | 10.1% (better) | 3.6% |
| Shareholder yield | 11.7% (better) | 3.6% |
| Ownership | ||
| Held by institutions | 96.7% | 99.9% |
| Held by insiders | 3.7% | 3.6% |
| Insider net buying, 12 months | −$16.8M (better) | −$17.0M |
| Short interest, % of float | 3.9% | 3.0% |
Go deeper
- ESNT stock overview
- ESNT income statement
- ESNT valuation and score
- NMIH stock overview
- NMIH income statement
- NMIH valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.